670 related articles for article (PubMed ID: 19059004)
21. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens.
Dey AK; Srivastava IK
Expert Rev Vaccines; 2011 Feb; 10(2):227-51. PubMed ID: 21105782
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin M as a vaccine adjuvant.
Ilag LL
Med Hypotheses; 2011 Oct; 77(4):473-8. PubMed ID: 21723670
[TBL] [Abstract][Full Text] [Related]
23. [The importance of the second generation adjuvanted systems in "new" vaccines].
Beran J
Klin Mikrobiol Infekc Lek; 2008 Feb; 14(1):5-12. PubMed ID: 18327735
[TBL] [Abstract][Full Text] [Related]
24. The science of adjuvants.
Kwissa M; Kasturi SP; Pulendran B
Expert Rev Vaccines; 2007 Oct; 6(5):673-84. PubMed ID: 17931149
[TBL] [Abstract][Full Text] [Related]
25. The path to a successful vaccine adjuvant--'the long and winding road'.
O'Hagan DT; De Gregorio E
Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
[TBL] [Abstract][Full Text] [Related]
26. Starch microparticles as vaccine adjuvant.
Rydell N; Stertman L; Sjöholm I
Expert Opin Drug Deliv; 2005 Sep; 2(5):807-28. PubMed ID: 16296780
[TBL] [Abstract][Full Text] [Related]
27. Resiquimod and other immune response modifiers as vaccine adjuvants.
Tomai MA; Miller RL; Lipson KE; Kieper WC; Zarraga IE; Vasilakos JP
Expert Rev Vaccines; 2007 Oct; 6(5):835-47. PubMed ID: 17931162
[TBL] [Abstract][Full Text] [Related]
28. New developments in vaccine research--unveiling the secret of vaccine adjuvants.
de Veer M; Meeusen E
Discov Med; 2011 Sep; 12(64):195-204. PubMed ID: 21955847
[TBL] [Abstract][Full Text] [Related]
29. Biomaterials as vaccine adjuvants.
Jones KS
Biotechnol Prog; 2008; 24(4):807-14. PubMed ID: 19194892
[TBL] [Abstract][Full Text] [Related]
30. Natural products and the search for novel vaccine adjuvants.
Rey-Ladino J; Ross AG; Cripps AW; McManus DP; Quinn R
Vaccine; 2011 Sep; 29(38):6464-71. PubMed ID: 21787827
[TBL] [Abstract][Full Text] [Related]
31. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
Nordly P; Madsen HB; Nielsen HM; Foged C
Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
[TBL] [Abstract][Full Text] [Related]
32. Immunomodulators as adjuvants for vaccines and antimicrobial therapy.
Nicholls EF; Madera L; Hancock RE
Ann N Y Acad Sci; 2010 Dec; 1213():46-61. PubMed ID: 20946578
[TBL] [Abstract][Full Text] [Related]
33. Targeting intracellular signaling: a novel approach to vaccination.
Wales J; Foxwell B; Feldmann M
Expert Rev Vaccines; 2007 Dec; 6(6):971-80. PubMed ID: 18377359
[TBL] [Abstract][Full Text] [Related]
34. Liposomal vaccine delivery systems.
Henriksen-Lacey M; Korsholm KS; Andersen P; Perrie Y; Christensen D
Expert Opin Drug Deliv; 2011 Apr; 8(4):505-19. PubMed ID: 21413904
[TBL] [Abstract][Full Text] [Related]
35. Taking a toll road to better vaccines.
Morley SC; Allen PM
Immunity; 2008 May; 28(5):602-4. PubMed ID: 18482564
[TBL] [Abstract][Full Text] [Related]
36. Cationic liposomes as vaccine adjuvants.
Christensen D; Korsholm KS; Andersen P; Agger EM
Expert Rev Vaccines; 2011 Apr; 10(4):513-21. PubMed ID: 21506648
[TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory biomaterials.
Mallapragada SK; Narasimhan B
Int J Pharm; 2008 Dec; 364(2):265-71. PubMed ID: 18662761
[TBL] [Abstract][Full Text] [Related]
38. The future of toll-like receptor therapeutics.
Parkinson T
Curr Opin Mol Ther; 2008 Feb; 10(1):21-31. PubMed ID: 18228178
[TBL] [Abstract][Full Text] [Related]
39. Vaccine adjuvant technology: from theoretical mechanisms to practical approaches.
Schijns VE; Tangerås A
Dev Biol (Basel); 2005; 121():127-34. PubMed ID: 15962475
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant activities of saponins from traditional Chinese medicinal herbs.
Song X; Hu S
Vaccine; 2009 Aug; 27(36):4883-90. PubMed ID: 19559122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
